Last Updated: Tuesday, August 22, 8:46 AM EDT
Launch our feature: The evolution of AIDS
Worldwide, nearly 40 million people are infected with HIV/AIDS and 25 million have died of the disease. To gain perspective on the pandemic around the globe and here at home, view our interactive feature
Political leaders accused of AIDS genocide
Failure to invest heavily in fighting disease is crime, head of international body says
Delivering vital medical care — on the house
Requests at the free health clinic range from HIV tests to leg-brace repair
Drug access is critical, activists warn
Crisis looms for world's poorest countries in need of costly ‘second-line' medication
Playing up the ‘play safe' message
For the first time, conference looks at sport as a tool for educating the next generation
Microbicides a new champion in AIDS fight
Easy-to-apply gels could save millions through prevention, researchers say
Economics
Bank charts disease's steep economic cost
Rich and poor nations must look beyond the humanitarian crisis that is HIV/AIDS and see that it will also devastate their economies
Research
Genetic mutation acts as a shield
Why do some HIV patients fare better than others?
The smartest virus in history?
Medical reporter Carolyn Abraham charts the course of a global pandemic
New HIV drug appears to be ‘very potent'
Rapid reduction in patients' viral load a promising outcome of early clinical trials
Four-drug cocktail no better, study finds
Triple mixture just as good at curbing HIV
In quest for vaccine, failure becomes an effective teacher
Company looks to repeat 3TC feat
Drug in development has 'completely new mechanism of action'
The race is on for Canadian firms
HIV 'too clever' for single approach, so combining drugs could be best way to keep it at bay
Drug holds promise of new first-line AIDS treatment
Research into a new family of drugs to be unveiled at AIDS Conference is raising hopes that there could soon be another first-line treatment against HIV
Opinions
Web-exclusive comment: AIDS conference
These meetings may have grown unwieldy, but they are important, writes Joe Amon of Human Rights Watch.
Canada's generic drug law is all talk, no action
Despite the Jean Chr?tien Pledge to Africa, not a single generic antiretroviral has made its way to world's poorest patients via the program in two years, writes Rachel Kiddell-Monroe
Born to be infected: We still can't protect our girls
The violation of women's rights continues to fuel the spread of HIV/AIDS, says Dorothy Aken'Ova
Editorial: The AIDS imperative
Somehow Ottawa must find a better way to tackle AIDS
Conference news
‘Rational discussion' scarce at AIDS conference, Clement says
Activists and “so-called experts” have skewed dialogue towards grandstanding political demands, Health Minister says
A fine balance between rights and successful HIV testing
Testing is one of the great conundrums of AIDS, something people are wrestling with all over Africa
Pressure mounts to keep injection site
Supporters of a safe-injection site for IV drug users demand to know whether federal government was going to renew its legal exemption
The African state: an AIDS survivor
They aren't thriving, but the countries hit worst by disease refuse to collapse, Stephanie Nolen finds
A 'lucky' few survived the early days of AIDS
In the mid- '80s, a diagnosis of HIV was almost a death sentence; today, new therapies offer hope for long lives
AIDS pandemic puts grandparents on the front line
More than half of all orphaned children in hardest-hit African countries live with grandparents
Lewis urges action in AIDS war
UN's special envoy issues 'direct challenge' for PM to back global four-point platform
Bold shift proposed in AIDS battle
Researcher's controversial idea: Curb transmission by dispensing drugs to all with HIV
The war on AIDS hits home
Education, prevention must be priorities, because many Canadians view the disease as a distant global problem, experts say
More treatment equals less transmission?
B.C. experts to launch pilot study in Vancouver



















